Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis

Stephanie M Holmer1, Kathy S Evans, Yohannes G Asfaw

  • 1Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA.

Infection and Immunity
|January 31, 2014
PubMed

Insights

Surfactant protein D (SP-D) increases susceptibility to Cryptococcus neoformans lung infections by promoting interleukin-5 (IL-5) and eosinophil infiltration. SP-D deficient mice show reduced fungal burden and increased survival.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Mycology

Background:

  • Cryptococcus neoformans is an opportunistic fungal pathogen causing pulmonary infections.
  • Surfactant protein D (SP-D) typically protects against respiratory infections but not C. neoformans.
  • SP-D deficient mice exhibit lower fungal burden and increased survival after C. neoformans infection.

Purpose of the Study:

  • To investigate how SP-D influences the pulmonary immune response to C. neoformans.
  • To determine the role of IL-5 and eosinophils in SP-D-mediated susceptibility.
  • To elucidate the mechanism by which SP-D affects C. neoformans infection outcomes.

Main Methods:

  • Comparison of inflammatory cells and cytokines in bronchoalveolar lavage fluid of wild-type (WT) and SP-D deficient mice post-infection.
  • Infection of mice with altered eosinophil and IL-5 levels with C. neoformans.
  • Genetic crossing of IL-5-overexpressing mice with SP-D deficient mice.

Main Results:

  • SP-D deficient mice showed reduced pulmonary eosinophil infiltration and IL-5 levels.
  • Mice overexpressing IL-5 exhibited increased pulmonary eosinophilia and susceptibility to C. neoformans.
  • Restoring IL-5 and eosinophils in SP-D deficient mice normalized susceptibility to WT levels.

Conclusions:

  • SP-D exacerbates C. neoformans infection by promoting pulmonary IL-5 and eosinophil infiltration.
  • IL-5 and eosinophils are key mediators of SP-D's detrimental effect on C. neoformans immunity.
  • Targeting SP-D or IL-5 pathways may offer therapeutic strategies against cryptococcal lung infections.